Fabrazyme Genzyme Corp - Treatment for Fabry Disease

Fabrazyme is a recombinant form of human alpha-galactosidase A, administered intravenously for the treatment of Fabry Disease.

Posted: April 2003

View comments

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web4)